Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

BioPorto - Building the Global Commercial Platform

By HC Andersen Capital
BioPorto

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

Mest and ask questions to Jennifer Zonderman, Senior Vice President Global Marketing & US Commercialization, and hear her present the market characteristics and BioPorto's global commercial strategy within AKI diagnostics on 22 October at 2.00 PM.

Disclaimer: HC Andersen Capital receives payment from Bioporto for a DigitalIR/Corporate Visibility and IR advisory agreement./Claus Thestrup 11 October 1.31 PM. (Updated 22 October 13.40)

Recent videos

GomSpace - Strategic direction & Q&A
2026-01-19 14:00 GomSpace Group
Oncopeptides, Audiocast, Investor Conference, 2026
2026-01-16 09:00 Oncopeptides
Duell, Webcast, Q1'26
2026-01-14 09:30 Duell
Dustin Group, Audiocast, Q1'26
2026-01-14 09:00 Dustin Group
Herantis Pharma Plc, Phase 1b biomarker data webcast
2026-01-08 11:00 Herantis Pharma
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.